Pediatric firearm injuries: Racial disparities and predictors of healthcare outcomes

Byron D Hughes1, Claire B Cummins1, Yong Shan1

  • 1Department of Surgery, University of Texas Medical Branch, 301 University Blvd., Galveston, TX, 77555, USA.

Insights

Pediatric firearm injuries show racial disparities in causes and outcomes. While White children were more likely to die from unintentional injuries or suicide, Black and Hispanic children faced higher assault-related injury rates.

Area of Science:

  • Public Health
  • Pediatric Trauma
  • Health Disparities

Background:

  • Firearm injuries represent a significant public health crisis in the U.S., particularly among children.
  • Existing data lacks comprehensive understanding of racial disparities in pediatric firearm injury outcomes.
  • Predictors of mortality, hospitalization costs, and length of stay require further investigation.

Purpose of the Study:

  • To analyze racial disparities in pediatric firearm injuries.
  • To assess hospitalization costs, length of stay (LOS), and inpatient mortality.
  • To identify differences in injury intent and survival rates across racial groups.

Main Methods:

  • Utilized the national Kids' Inpatient Databases (KID) from 2006-2012.
  • Included pediatric hospitalizations (age ≤18) with firearm injury diagnoses.
  • Employed regression models to examine mortality, costs, and LOS, analyzing injury intent and weapon type by race.

Main Results:

  • Over 15,000 pediatric hospitalizations for firearm injuries were analyzed.
  • Assault accounted for the majority (60%) of injuries, with intent varying significantly by race (p < 0.001).
  • Black and Hispanic children had lower odds of inpatient mortality compared to White children (OR 0.41 and 0.47, respectively).

Conclusions:

  • Circumstances and survival rates of pediatric firearm injuries differ notably by race.
  • White children are more prone to unintentional injuries and suicides.
  • Black and Hispanic children are disproportionately affected by inflicted firearm injuries.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
198
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
156
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
185
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
182
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
143
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.5K